Perioperative Medication Management for Lumpectomy
None of these medications need to be held before lumpectomy. Continue anastrozole, atorvastatin, and irbesartan through the perioperative period.
Medication-Specific Recommendations
Anastrozole (Aromatase Inhibitor)
Continue without interruption. Recent expert consensus specifically addressing anticancer agents in breast reconstruction found that aromatase inhibitors do not need to be held for elective breast surgery procedures 1. Anastrozole has no significant impact on surgical bleeding risk or wound healing, and maintaining hormonal therapy continuity is important for oncologic outcomes. The medication can be taken on the morning of surgery and resumed immediately postoperatively.
Atorvastatin (Statin)
Continue without interruption. The 2014 ACC/AHA perioperative guidelines provide a Class I recommendation (Level of Evidence B) to continue statins in patients currently taking them who are scheduled for noncardiac surgery 2, 3. Statins have been shown to reduce perioperative cardiovascular events, and abrupt discontinuation may increase cardiac risk 2. The patient should take atorvastatin on the morning of surgery and continue daily throughout the perioperative period.
Irbesartan (ARB - Angiotensin Receptor Blocker)
Continuation is reasonable perioperatively. The 2014 ACC/AHA guidelines state that continuation of ACE inhibitors or ARBs is reasonable perioperatively (Class IIa recommendation, Level of Evidence B) 2, 3. While there is some debate about ARBs causing intraoperative hypotension, the evidence supports continuation, particularly for a minor procedure like lumpectomy. If held, it should be restarted as soon as clinically feasible postoperatively 2.
However, a practical approach for this specific case: Given that lumpectomy is a relatively minor surgical procedure with low bleeding risk and typically performed under local anesthesia with sedation or general anesthesia of short duration, the risk of significant intraoperative hypotension from irbesartan is minimal. The guideline evidence supports continuation 4, 5.
Clinical Rationale
The key principle is that chronic medications should generally be continued perioperatively to maintain patient stability 6. For this 76-year-old patient:
- Lumpectomy is a low-risk procedure with minimal bleeding risk and short operative time
- None of these medications affect coagulation or significantly increase surgical bleeding
- Cardiovascular stability is maintained by continuing the statin and ARB
- Oncologic therapy continuity is preserved by continuing anastrozole
Practical Instructions
Day of Surgery:
- Take all three medications on the morning of surgery with a sip of water
- No interruption needed preoperatively
Postoperatively:
- Resume all medications on their regular schedule the evening of surgery or the next morning
- No dose adjustments required
Important Caveats
The evidence provided focuses heavily on antiplatelet agents and anticoagulants, which are not relevant to this patient. The specific medications in question (anastrozole, atorvastatin, irbesartan) have clear guidance supporting continuation. The only medication requiring any consideration is irbesartan, where continuation remains reasonable for this low-risk procedure, though some practitioners might hold it the morning of surgery and restart postoperatively if concerned about intraoperative hypotension—but this is not mandated by guidelines 2.